NCYT — Novacyt SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Novacyt SA, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	277	92.6	21	10.6	19.6
Cost of Revenue
Gross Profit	212	28.2	5.75	3.49	32.1
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	110	96.6	44.4	36.1	57
Operating Profit	167	-3.98	-23.4	-25.4	-37.3
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	165	-5.66	-20.1	-24.5	-39.4
Provision for Income Taxes
Net Income After Taxes	132	-6.01	-22.2	-24.1	-38.7
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	132	-9.73	-25.7	-28.3	-41.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	132	-9.73	-25.7	-28.3	-41.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.03	-0.037	-0.229	-0.237	-0.341
Dividends per Share